Immunogenic composition for use in vaccination against staphylococcei

Details for Australian Patent Application No. 2005287502 (hide)

Owner GlaxoSmithKline Biologicals s.a.

Inventors Lecrenier, Nicolas Pierre Fernand; Poolman, Jan; Neyt, Cecile Anne; Castado, Cindy

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005287502

PCT Pub. Number WO2006/032472

Priority 0503143.0 15.02.05 GB; 0421078.7 22.09.04 GB; 0421081.1 22.09.04 GB; 0421079.5 22.09.04 GB; 0421082.9 22.09.04 GB

Filing date 20 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 1 December 2011

International Classifications

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

A61K 39/085 (2006.01) Medicinal preparations containing antigens or antibodies - Staphylococcus

A61K 39/116 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent bacterial antigens

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/032472 Priority application(s): WO2006/032472

1 December 2011 Application Accepted

  Published as AU-B-2005287502

29 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005287505-Staphylococcal immunogenic compositions

2005287499-Stress resistant plants